Featured
The Biometric Beauty Monopoly: How Synthetic Biology and Neuro-Cosmetics Are Rewiring the $400B Prestige Economy
L'Oréal’s $2.8B synthetic biology acquisition and the FDA’s microbiome reclassification mark the definitive pivot of the prestige beauty sector f...
Read Full Story →